A small molecule bidentate-binding dual inhibitor probe of the LRRK2 and JNK kinases

ACS Chemical Biology

Volumn 8, Issue 8, 2013, Pages 1747-1754

  Feng, Yangbo ^a   Chambers, Jeremy W ^a   Iqbal, Sarah ^a   Koenig, Marcel ^a   Park, Hajeung ^a   Cherry, Lisa ^a   Hernandez, Pamela ^a   Figuera Losada, Mariana ^a   Lograsso, Philip V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LEUCINE RICH REPEAT KINASE 2; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG POTENCY; DRUG SYNTHESIS; IC 50; MOLECULAR PROBE; PRIORITY JOURNAL;

BENZOFURANS; BINDING SITES; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INDAZOLES; INHIBITORY CONCENTRATION 50; MAP KINASE KINASE 4; MODELS, MOLECULAR; MOLECULAR PROBES; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SMALL MOLECULE LIBRARIES;

EID: 84882758496     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb3006165     Document Type: Article

References (41)

1. Borsello, T., Clarke, P. G., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., and Bonny, C. (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia Nat. Med. 9, 1180-1186
2. Chambers, J. W., Pachori, A., Howard, S., Ganno, M., Hansen, D., Jr., Kamenecka, T., Song, X., Duckett, D., Chen, W., Ling, Y. Y., Cherry, L., Cameron, M. D., Lin, L., Ruiz, C. H., and Lograsso, P. (2011) Small molecule c-jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson'S disease ACS Chem. Neurosci. 2, 198-206
3. Crocker, C. E., Khan, S., Cameron, M. D., Robertson, H. A., Robertson, G. S., and LoGrasso, P. (2011) JNK inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson'S disease ACS Chem. Neurosci. 2, 207-212
4. Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D., Matsuoka, T. A., Matsuhisa, M., Kajimoto, Y., Ichijo, H., Yamasaki, Y., and Hori, M. (2004) Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide Nat. Med. 10, 1128-1132
5. Lee, B. D., Shin, J. H., VanKampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y. I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., Dawson, V. L., and Dawson, T. M. (2010) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease Nat. Med. 16, 998-1000
6. Choi, H. G., Zhang, J., Deng, X., Hatcher, J. M., Patricelli, M. P., Zhao, Z., Alessi, D. R., and Gray, N. S. (2012) Brain Penetrant LRRK2 Inhibitor ACS Med. Chem. Lett. 3, 658-662
7. Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J. D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R., and Gray, N. S. (2011) Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 Nat. Chem. Biol. 7, 203-205
8. Chen, H., Chan, B. K., Drummond, J., Estrada, A. A., Gunzner-Toste, J., Liu, X., Liu, Y., Moffat, J., Shore, D., Sweeney, Z. K., Tran, T., Wang, S., Zhao, G., Zhu, H., and Burdick, D. J. (2012) Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling J. Med. Chem. 55, 5536-5545
9. Estrada, A. A., Liu, X., Baker-Glenn, C., Beresford, A., Burdick, D. J., Chambers, M., Chan, B. K., Chen, H., Ding, X., Dipasquale, A. G., Dominguez, S. L., Dotson, J., Drummond, J., Flagella, M., Flynn, S., Fuji, R., Gill, A., Gunzner-Toste, J., Harris, S. F., Heffron, T. P., Kleinheinz, T., Lee, D. W., Le Pichon, C. E., Lyssikatos, J. P., Medhurst, A. D., Moffat, J., Mukund, S., Nash, K., Scearce-Levie, K., Sheng, Z., Shore, D., Tran, T., Trivedi, N., Wang, S., Zhang, S., Zhang, X., Zhao, G., Zhu, H., and Sweeney, Z. K. (2012) Discovery of highly potent, selective, and brain penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors J. Med. Chem. 55, 9416-9433
10. Kramer, T., Lo Monte, F., Goring, S., Amombo, G. M. O., and Schmidt, B. (2012) Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models ACS Chem. Neurosci. 3, 151-160
11. Yoon, S. O., Park, D. J., Ryu, J. C., Ozer, H. G., Tep, C., Shin, Y. J., Lim, T. H., Pastorino, L., Kunwar, A. J., Walton, J. C., Nagahara, A. H., Lu, K. P., Nelson, R. J., Tuszynski, M. H., and Huang, K. (2012) JNK3 perpetuates metabolic stress induced by Abeta peptides Neuron 75, 824-837
12. Morfini, G. A., You, Y. M., Pollema, S. L., Kaminska, A., Liu, K., Yoshioka, K., Bjorkblom, B., Coffey, E. T., Bagnato, C., Han, D., Huang, C. F., Banker, G., Pigino, G., and Brady, S. T. (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin Nat. Neurosci. 12, 864-871
13. Maroney, A. C., Glicksman, M. A., Basma, A. N., Walton, K. M., Knight, E., Jr., Murphy, C. A., Bartlett, B. A., Finn, J. P., Angeles, T., Matsuda, Y., Neff, N. T., and Dionne, C. A. (1998) Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway J. Neurosci. 18, 104-111
14. Tran, E. H., Azuma, Y. T., Chen, M., Weston, C., Davis, R. J., and Flavell, R. A. (2006) Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain Proc. Natl. Acad. Sci. U.S.A. 103, 13451-13456
15. Bowers, S., Truong, A. P., Jeffrey Neitz, R., Hom, R. K., Sealy, J. M., Probst, G. D., Quincy, D., Peterson, B., Chan, W., Galemmo, R. A., Jr., Konradi, A. W., Sham, H. L., Toth, G., Pan, H., Lin, M., Yao, N., Artis, D. R., Zhang, H., Chen, L., Dryer, M., Samant, B., Zmolek, W., Wong, K., Lorentzen, C., Goldbach, E., Tonn, G., Quinn, K. P., Sauer, J. M., Wright, S., Powell, K., Ruslim, L., Ren, Z., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2011) Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration Bioorg. Med. Chem. Lett. 21, 5521-5527
16. Bowers, S., Truong, A. P., Neitz, R. J., Neitzel, M., Probst, G. D., Hom, R. K., Peterson, B., Galemmo, R. A., Jr., Konradi, A. W., Sham, H. L., Toth, G., Pan, H., Yao, N., Artis, D. R., Brigham, E. F., Quinn, K. P., Sauer, J. M., Powell, K., Ruslim, L., Ren, Z., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2011) Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor Bioorg. Med. Chem. Lett. 21, 1838-1843
17. He, Y., Kamenecka, T. M., Shin, Y., Song, X., Jiang, R., Noel, R., Duckett, D., Chen, W., Ling, Y. Y., Cameron, M. D., Lin, L., Khan, S., Koenig, M., and LoGrasso, P. V. (2011) Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors Bioorg. Med. Chem. Lett. 21, 1719-1723
18. Fabian, M. A., Biggs, W. H., 3rd, Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., Ford, J. M., Galvin, M., Gerlach, J. L., Grotzfeld, R. M., Herrgard, S., Insko, D. E., Insko, M. A., Lai, A. G., Lelias, J. M., Mehta, S. A., Milanov, Z. V., Velasco, A. M., Wodicka, L. M., Patel, H. K., Zarrinkar, P. P., and Lockhart, D. J. (2005) A small molecule-kinase interaction map for clinical kinase inhibitors Nat. Biotechnol. 23, 329-336
19. Probst, G. D., Bowers, S., Sealy, J. M., Truong, A. P., Hom, R. K., Galemmo, R. A., Jr., Konradi, A. W., Sham, H. L., Quincy, D. A., Pan, H., Yao, N., Lin, M., Toth, G., Artis, D. R., Zmolek, W., Wong, K., Qin, A., Lorentzen, C., Nakamura, D. F., Quinn, K. P., Sauer, J. M., Powell, K., Ruslim, L., Wright, S., Chereau, D., Ren, Z., Anderson, J. P., Bard, F., Yednock, T. A., and Griswold-Prenner, I. (2011) Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration Bioorg. Med. Chem. Lett. 21, 315-319
20. Delaney, A. M., Printen, J. A., and Chen, H. 2002, Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352 Mol. Cell. Biol. 22 (21) 7593-7602
21. Liu, Y. and Gray, N. S. (2006) Rational design of inhibitors that bind to inactive kinase conformations Nat. Chem. Biol. 2, 358-364
22. Feng, Y., Yin, Y., Weiser, A., Griffin, E., Cameron, M. D., Lin, L., Ruiz, C., Schurer, S. C., Inoue, T., Rao, P. V., Schroter, T., and LoGrasso, P. (2008) Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2- carboxamides as potent and highly selective rho kinase (ROCK-II) inhibitors J. Med. Chem. 51, 6642-6645
23. Fang, X., Yin, Y., Chen, Y. T., Yao, L., Wang, B., Cameron, M. D., Lin, L., Khan, S., Ruiz, C., Schroter, T., Grant, W., Weiser, A., Pocas, J., Pachori, A., Schurer, S. C., LoGrasso, P., and Feng, Y. (2010) Tetrahydroisoquinoline derivatives as highly selective and potent rho kinase inhibitors J. Med. Chem. 53, 5727-5737
24. Conway, J. G., McDonald, B., parham, J., Keith, B., Rusnak, D. W., Shaw, E., Jansen, M., Lin, P., payne, A., Crosby, R. M., Johnson, J. H., Frick, L., Lin, M. J., Depee, S., tadepalli, S., Votta, B., James, I., Fuller, K., Chambers, T. J., Kull, F. C., Chamberlain, S. D., and Hutchins, J. T. (2005) Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 Proc. Nat. Assoc. Sci. U.S.A. 102, 16078-16083
25. Jani, J. P., Finn, R. S., Chambell, M., Coleman, K. G., Connell, R. D., Currier, N., Emerson, E. O., Floyd, E., harriman, S., Kath, J. C., Morris, J., Moyer, J. D., Pustilnik, L. R., Rafidi, K., ralston, S., Rossi, A. M. K., Steyn, S. J., Wagner, L., Winter, S. M., and Bhattacharya, S. K. (2007) Discovery and pharmacologic characterization of CP-724,714, and a selective ErbB2 tyrosine kinase inhibitor Cancer Res. 67, 9887-9893
26. Davis, M. I., Hunt, J. P., herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., and Zarrinkar, P. P. (2011) Comprehensive analysis of kinase inhibitor selectivity Nat. Biotechnol. 29, 1046-1052
27. Stebbins, J. L., De, S. K., Pavlickova, P., Chen, V., Machleidt, T., Chen, L. H., Kuntzen, C., Kitada, S., Karin, M., and Pellecchia, M. (2011) Design and characterization of a potent and selective dual ATP- and substrate competitive sub-nanomolar bi-dentate c-Jun N-terminal Kinase (JNK) inhibitor J. Med. Chem. 54, 6206-6214
28. Vazquez, J., De, S. K., Chen, L. H., Riel-Mehan, M., Emdadi, A., Cellitti, J., Stebbins, J. L., Rega, M. F., and Pellecchia, M. (2008) Development of paramagnetic probes for molecular recognition studies in protein kinases J. Med. Chem. 51, 3460-3465
29. Laughlin, J. D., Nwachukwu, J. C., Figuera-Losada, M., Cherry, L., Nettles, K. W., and LoGrasso, P. V. (2012) Structural mechanisms of allostery and autoinhibition in JNK family kinases Structure 20, 2174-2184
30. Barr, R. K., Boehm, I., Attwood, P. V., Watt, P. M., and Bogoyevitch, M. A. (2004) The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK J. Biol. Chem. 279, 36327-36338
31. Barr, R. K., Kendrick, T. S., and Bogoyevitch, M. A. (2002) Identification of the critical features of a small peptide inhibitor of JNK activity J. Biol. Chem. 277, 10987-10997
32. Heo, Y. S., Kim, S. K., Seo, C. I., Kim, Y. K., Sung, B. J., Lee, H. S., Lee, J. I., Park, S. Y., Kim, J. H., Hwang, K. Y., Hyun, Y. L., Jeon, Y. H., Ro, S., Cho, J. M., Lee, T. G., and Yang, C. H. (2004) Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 EMBO J. 23, 2185-2195
33. Ho, D. T., Bardwell, A. J., Grewal, S., Iverson, C., and Bardwell, L. (2006) Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases J. Biol. Chem. 281, 13169-13179
34. Ember, B., Kamenecka, T., and LoGrasso, P. (2008) Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1 Biochemistry 47, 3076-3084
35. Figuera-Losada, M. and LoGrasso, P. V. (2012) Enzyme kinetics and interaction studies for human JNK1beta1 and substrates activating transcription factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun) J. Biol. Chem. 287, 13291-13302
36. Chen, Y. T., Bannister, T. D., Weiser, A., Griffin, E., Lin, L., Ruiz, C., Cameron, M. D., Schürer, S., Duckett, D., Schröter, T., LoGrasso, P., and Feng, Y. (2008) Chroman-3-amides as potent Rho kinase inhibitors Bioorg. Med. Chem. Lett. 18, 6406-6409
37. Chen, T., Kablaoui, N., Little, L., Timofeevski, S., Tschantz, W. R., Chen, P., Feng, J., Charlton, M., Stanton, R., and Bauer, P. (2009) Identification of small-molecule inhibitors of the JIP-JNK interaction Biochem. J. 420, 283-294
38. LoGrasso, P. and Feng, Y. (2009) Rho kinase (ROCK) inhibitors and their application to inflammatory disorders Curr. Top. Med. Chem. 9, 704-723
39. Iwakubo, M., Takami, A., Okada, Y., Kawata, T., Tagami, Y., Ohashi, H., Sato, M., Sugiyama, T., Fukushima, K., and Iijima, H. (2007) Design and synthesis of Rho kinase inhibitors (II) Bioorg. Med. Chem. 15, 350-367
40. Chambers, J. W., Cherry, L., Laughlin, J. D., Figuera-Losada, M., and Lograsso, P. V. (2011) Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1) ACS Chem. Biol. 6, 808-818
41. Chambers, J. W. and Lograsso, P. V. (2011) Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation J. Biol. Chem. 286, 16052-16062